The project will involve improving BioVisioN's proprietary Peptidomics Technologies, which are used for the analysis of peptides and small molecules, to allow for higher throughput and better sensitivity and reproducibility, the company said.
In addition, the grant will fund the sequencing of peptides in blood and plasma, and the development of new methods for diagnostic applications.